Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trialsYoshiya Tanaka, Hideto Kameda, Mariko Sumi et al.|Modern Rheumatology|2021Cited by 5